Clinical Congress Research Articles

Late Breaking Oral Abstract Session LB OAS 1

AllergyVolume 70, Issue S101 p. 107-112 Late Breaking Oral Abstract Session LB OAS 1Free Access Late Breaking Oral Abstract Session LB OAS 1 First published: 22 September 2015 https://doi.org/10.1111/all.12716AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Volume70, IssueS101Special Issue: Abstracts from the European Academy of Allergy and Clinical Immunology Congress, 6–10 June 2015, Barcelona, SpainSeptember 2015Pages 107-112 RelatedInformation

Abstracts from the European Academy of Allergy and Clinical Immunology Congress, 6-10 June 2015, Barcelona, Spain.

AllergyVolume 70, Issue S101 p. 1-106 Oral Abstract Session OAS 1Free Access Oral Abstract Session OAS 1 First published: 22 September 2015 https://doi.org/10.1111/all.12715Citations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume70, IssueS101Special Issue: Abstracts from the European Academy of Allergy and Clinical Immunology Congress, 6–10 June 2015, Barcelona, SpainSeptember 2015Pages 1-106 RelatedInformation

51st Congress of the Italian Association of Neuropathology and Clinical Neurobiology (AINPeNC) and 41st Congress of the Italian Association for Research on Brain Aging (AIRIC), Verona, Italy, June 4 – 6, 2015

51st Congress of the Italian Association of Neuropathology and Clinical Neurobiology (AINPeNC) and 41st Congress of the Italian Association for Research on Brain Aging (AIRIC), Verona, Italy, June 4 – 6, 2015

Self-Assessment Test

Supplement from a live satellite symposium, conducted in Las Vegas, NV, on May 15, 2014, in conjunction with the American Association of Clinical Endocrinologists 23rd Annual Scientific and Clinical Congress.

Second clinical congress of the gulf chapter of the american association of clinical endocrinologists, october, 23rd-25th 2014, Abu Dhabi, United Arab Emirates

These are the advance abstracts of the second clinical congress of the Gulf Chapter of the American Association of Clinical Endocrinologists to be held on 23-25 of October 2014. The declared educational objectives of the congress is to give a “state of the art in endocrine practice”. To this end, the organizing committee invited international and regional key opinion leaders to meet the objectives of the congress. We present the abstracts of the congress as submitted by the authors after minimal restyling and editing to suit the publication requirements of the journal. Many major issues and topical themes with wide interests in the profession were addressed in 5 plenary lectures. A clinical practice debate was included to highlight the pros and cons of the recently published lipid lower guidelines from both sides of the Atlantic. More focused issues were included in 12 clinical practice symposia to suite the specific educational needs of the target audience subgroups. Practical issues were addressed in “Meet the Expert”-type of interactive workshops. A selection of free communications from abstracts submitted by delegates, reflecting mostly the regional epidemiology and clinical practice in diabetes care and endocrinology, were selected for presentation as either oral or poster presentations.We hope that by publishing them in this journal we extend the benefit to those who could not make it to the live presentations. The focus of this year's congress included bone health, molecular endocrinology, pituitary and adrenal disease, new advances in diabetes care, nuclear medicine in endocrinology and select topical issues in addition to many other day to day concerns in diabetes care and clinical endocrinology.

Poster Session Group I

AllergyVolume 69, Issue s99 p. 200-325 Poster Session Group IFree Access Poster Session Group I First published: 25 August 2014 https://doi.org/10.1111/all.12476Citations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume69, Issues99Special Issue: Abstracts from the European Academy of Allergy and Clinical Immunology Congress, 7–11 June 2014, Copenhagen, DenmarkSeptember 2014Pages 200-325 RelatedInformation

Poster Session Group III

AllergyVolume 69, Issue s99 p. 454-572 Poster Session Group III Poster Session Group III First published: 25 August 2014 https://doi.org/10.1111/all.12478Citations: 17AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume69, Issues99Special Issue: Abstracts from the European Academy of Allergy and Clinical Immunology Congress, 7–11 June 2014, Copenhagen, DenmarkSeptember 2014Pages 454-572 RelatedInformation

Scudder Oration on Trauma. A century of evolution in trauma resuscitation.

Division of Trauma, Burn, General and Critical Care Surgery, Department of Surgery, Harborview Medical Center, University of Washington, Seattle, WA *Correspondence address: Ronald V Maier, MD, FACS, Department of Surgery, Harborview Medical Center, 325 Ninth Ave, Seattle, WA 98104-2499. E-mail: [email protected] Received April 24, 2014; accepted April 28, 2014. Disclosure Information: Nothing to disclose. Presented at the American College of Surgeons 99th Annual Clinical Congress, Washington, DC, October 2013.

Disclosure of Funding Sources and Conflicts of Interest in Phase III Surgical Trials: Survey of 10 General Surgery Journals

The last decade has shown burgeoning growth and the importance of industrial support for innovation and clinical trials that have advanced the practice of surgery. Quality clinical studies are expensive, as is the development of innovative technologies. The last decade has also shown only too clearly that some of those alliances have been abused by consequent bias of the outcomes or even for personal gain. As editors, we must be overly conscious of funding sources and especially situations of real or potential conflicts of interest. Editors, often informed by reviewers, must be on the look-out for malfeasance. However, as Tuech and colleagues have shown, we may miss some who stray from the righteous path. We thus fail in our responsibility to our readers to provide funding sources and how the ‘‘funding’’ was disbursed: for salary support of investigator, nurse, or study coordinator; materials/devices/medications used; data analysis; preparation of manuscript; unrestricted monetary ‘‘grants’’ often used for activities unrelated to the study at hand. Although we very closely and consciously review conflicts of interest that have been disclosed, there are others that were not disclosed, regardless of whether it was intentional. In those circumstances, neither we nor our readers are able to judge the validity of the reported data. Tuech et al. [1] have asked the question, and we, the Editors-in-Chief of the journal, SURGERY, as well as the Editor-in-Chief of the World Journal of Surgery, have heard them. We will address this topic at the next meeting of the Surgery Journal Editors Group (SJEG) this fall during the Clinical Congress of the American College of Surgeons. Each year the SJEG, which has representatives from many of the indexed surgery journals, meets to discuss topics of relevance to the field of medical publishing such as this important topic. It seems likely that the SJEG will adopt a general policy that all articles specify the source (and use) of funding and the presence or absence of pertinent disclosures of interest. The journal Surgery, which we co-edit, is adopting this policy immediately.

The first clinical congress of the gulf chapter of the American association of clinical endocrinologists, october, 3rd-5th 2013, St Regis Hotel, Abu Dhabi, United Arab Emirates

The first clinical congress of the Gulf Chapter of the American Association of Clinical Endocrinologists was held in October 2013. The declared educational objective of the congress is to give a “state of the art in endocrine practice”. To this end, the organizing committee invited international and regional key opinion leaders to meet the objectives of the congress. In this article, we present the abstracts of the congress as submitted by the authors after minimal restyling and editing to suit the publication requirements of the journal. Major issues and topical themes with wide interests in the profession were addressed in 6 plenary lectures. More focused issues were included in several parallel symposia to suite the specific educational needs of the target audience subgroups. Practical issues were addressed in “Meet the Expert” type of interactive workshops. A selection of free communications from abstracts submitted by delegates, reflecting mostly the regional epidemiology and clinical practice in diabetes care and endocrinology, were presented as either oral or poster presentations. The abstracts are presented under their relevant groups. We hope that by publishing them in this journal we extend the benefit to those who could not make it to the live presentations.

Value of peritoneal cytology in potentially resectable pancreatic cancer

Peritoneal lavage cytology (CY) is used in the diagnosis and staging of various cancers. The clinical significance of positive cytology results in patients with pancreatic cancer is yet to be determined. Peritoneal washing samples were collected from consecutive patients with pancreatic cancer between July 1991 and December 2012. The correlations between cytology results, clinicopathological parameters and recurrence patterns were evaluated. The prognostic impact of CY status, regarding resectability and the effectiveness of adjuvant chemotherapy, were analysed. Of 523 included patients, 390 underwent resection. Patients with tumours at least 2 cm in diameter were more likely to have CY+ status than patients with tumours smaller than 2 cm (48 of 312 versus 3 of 78 respectively; P = 0·005) and there was a significant correlation between CY+ status and tumour invasion of the anterior pancreatic capsule (43 of 276 versus 8 of 113 with no invasion of the capsule; P = 0·030). Although the overall survival of patients with resected CY+ tumours was worse than that of patients with resected CY- tumours, it was significantly better than the survival of unresected patients regardless of CY status. Multivariable analysis of all patients who had pancreatectomy did not identify CY+ as an independent prognostic factor. Patients with CY+ tumours tended to develop peritoneal metastasis more often than those with CY- tumours, although not significantly so. The median survival time of 34 patients with resected CY+ tumours who received adjuvant chemotherapy was better than that of 17 patients who had surgery alone, although this was not statistically significant (15·3 versus 10·0 months; P = 0·057). CY+ status is not clinically equivalent to gross peritoneal metastasis in patients with pancreatic cancer. Curative resection is still recommended regardless of CY status.

Role of mTOR inhibition in the treatment of patients with renal angiomyolipomas

To describe the role of mammalian target of rapamycin (mTOR) inhibition in the treatment of tuberous sclerosis complex (TSC) patients with renal angiomyolipoma in relation to available clinical data and clinical practice guidance for the nurse practitioner (NP). A review of the scientific literature, key clinical congresses, and key clinical trials. TSC-associated renal angiomyolipomas have a propensity to grow over time and predispose patients to serious and life-threatening consequences. Surgery or invasive interventional therapies may not be the most optimal treatments because of the multiple, bilateral growth pattern of TSC-associated renal angiomyolipomas. Targeted therapies, such as mTOR inhibitors, which have demonstrated efficacy in maintaining and reducing renal angiomyolipoma size, are of great benefit to patients. Treatment with everolimus, an oral mTOR inhibitor, offers patients a noninvasive pharmacotherapeutic treatment option. The NP, as a key member of the healthcare team overseeing TSC patients, must be knowledgeable about the safety and efficacy of mTOR inhibitors as their use in the patient population increases.

EN

One hundred years ago, a group of surgeons from the United States and Canada founded the American College of Surgeons (ACS). Its origin lies in its journal, which was started 8 years earlier. Annual clinical congresses designed to promote the journal attracted so many surgeons from North America

Critical Skills for the Senior Medical Student Entering Surgery

Abstract Introduction Critical response skills focusing on the management of acute, life-threatening emergencies in postoperative patients are important topics that are not uniformly covered in med...

Organizations and Researchers Strive to Address Disparities in Cancer Care

Organizations and Researchers Strive to Address Disparities in Cancer Care

Clinical Trials Update Esc Congress 2011

Clinical Trials Update Esc Congress 2011

Reflections from the New world

I have returned recently from the American College of Surgeons (ACS) Annual Clinical Congress in San Francisco.This, as you might expect, is a huge event, with up to 15,000 delegates from all over the world. I have always had a sneaking admiration for the American 'can do' attitude, their ability to face up to problems and effectively address them in a rapid timeframe.

American Association for the Surgery of Trauma and the Clinical Congress of Acute Care Surgery 2011 Presidential Address

American Association for the Surgery of Trauma and the Clinical Congress of Acute Care Surgery 2011 Presidential Address

Does Duration of Perioperative Antibiotic Prophylaxis Matter in Cardiac Surgery? A Systematic Review and Meta-Analysis

We aimed to compare the efficacy of short-term (<24 hours) versus longer-term antibiotic prophylaxis (≥24 hours) in open heart surgery. The optimal duration of antibiotic prophylaxis for adults undergoing cardiac surgery is unknown and guideline recommendations are inconsistent. We searched MEDLINE, EMBASE, CINAHL, and CENTRAL for parallel-group randomized trials comparing any antibiotic prophylaxis administered for <24 hours to any antibiotic prophylaxis for ≥24 hours in adult patients undergoing open heart surgery. Reference lists of selected articles, clinical practice guidelines, review articles, and congress abstracts were searched. Study selection, data extraction and assessment of risk of bias were performed independently by 2 reviewers. Of the 1338 citations identified by our search strategy, 12 studies involving 7893 patients were selected. Compared with short-term antibiotic prophylaxis, longer-term antibiotic prophylaxis reduced the risk of sternal surgical site infection (SSI) by 38% (risk ratio 1.38, 95% confidence interval (CI) 1.13-1.69, P = 0.002) and deep sternal SSI by 68% (risk ratio 1.68, 95% CI 1.12-2.53, P = 0.01). There were no statistically significant differences in mortality, infections overall and adverse events. Eleven of the trials were at high risk for bias due to limitations in study design. Perioperative antibiotic prophylaxis of ≥24 hours may be more efficacious in preventing sternal SSIs in patients undergoing cardiac surgery compared to shorter regimens. The findings however are limited by the heterogeneity of antibiotic regimens used and the risk of bias in the published studies.

Surgery—call for papers

The American College of Surgeons' 97th Clinical Congress will be held in San Francisco, CA, USA, on Oct 23–27. The Lancet will again publish a surgery-themed issue to coincide with the meeting. 2 years ago, the Clinical Congress issue featured a new framework for the evaluation of surgical innovation. 1 Barkun JS Aronson JK Feldman LS Maddern GJ Strasberg SM for the Balliol CollaborationEvaluation and stages of surgical innovations. Lancet. 2009; 374: 1089-1096 Summary Full Text Full Text PDF PubMed Scopus (400) Google Scholar In 2010, our editorial reflected the Congress theme of professionalism. 2 The LancetWhat is the point of surgery?. Lancet. 2010; 376: 1025 Summary Full Text Full Text PDF PubMed Scopus (5) Google Scholar In addition to these areas of interest to our readers, The Lancet also invites original submissions that will advance thinking and practice within any branch of surgery or its related disciplines.